Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, et al.
Journal of Neuro-Oncology
|
September 28, 2010
Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases
Orestes E Solis, Rupal I Mehta, Albert Lai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis
Percy Lee, Wietse Eppinga, Frank Lagerwaard, et al.
Cancer Research
|
November 26, 2009
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model
Christina H Wang, Jason K Rockhill, Maciej Mrugala, et al.
Investigational New Drugs
|
August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs
Susan M Chang, John Kuhn, Patrick Wen, et al.
The New England Journal of Medicine
|
February 21, 2014
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
Olivier L Chinot, Wolfgang Wick, Warren Mason, et al.
Neuro-Oncology
|
March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study
H Ian Robins, Susan M Chang, Michael D Prados, et al.
Neuro-Oncology
|
March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
Isabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study
Kurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, et al.
Journal of Neuro-Oncology
|
September 28, 2010
Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases
Orestes E Solis, Rupal I Mehta, Albert Lai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis
Percy Lee, Wietse Eppinga, Frank Lagerwaard, et al.
Cancer Research
|
November 26, 2009
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model
Christina H Wang, Jason K Rockhill, Maciej Mrugala, et al.
Investigational New Drugs
|
August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs
Susan M Chang, John Kuhn, Patrick Wen, et al.
The New England Journal of Medicine
|
February 21, 2014
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
Olivier L Chinot, Wolfgang Wick, Warren Mason, et al.
Neuro-Oncology
|
March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study
H Ian Robins, Susan M Chang, Michael D Prados, et al.
Neuro-Oncology
|
March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
Isabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study
Kurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Page
of 10